Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 2
2012 3
2013 4
2014 5
2015 4
2016 3
2017 6
2018 5
2019 3
2020 1
2021 6
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Results by year
Filters applied: . Clear all
Page 1
Targeting the p300/CBP Axis in Lethal Prostate Cancer.
Welti J, Sharp A, Brooks N, Yuan W, McNair C, Chand SN, Pal A, Figueiredo I, Riisnaes R, Gurel B, Rekowski J, Bogdan D, West W, Young B, Raja M, Prosser A, Lane J, Thomson S, Worthington J, Onions S, Shannon J, Paoletta S, Brown R, Smyth D, Harbottle GW, Gil VS, Miranda S, Crespo M, Ferreira A, Pereira R, Tunariu N, Carreira S, Neeb AJ, Ning J, Swain A, Taddei D; SU2C/PCF International Prostate Cancer Dream Team, Schiewer MJ, Knudsen KE, Pegg N, de Bono JS. Welti J, et al. Among authors: schiewer mj. Cancer Discov. 2021 May;11(5):1118-1137. doi: 10.1158/2159-8290.CD-20-0751. Epub 2021 Jan 11. Cancer Discov. 2021. PMID: 33431496 Free PMC article.
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair.
Shafi AA, McNair CM, McCann JJ, Alshalalfa M, Shostak A, Severson TM, Zhu Y, Bergman A, Gordon N, Mandigo AC, Chand SN, Gallagher P, Dylgjeri E, Laufer TS, Vasilevskaya IA, Schiewer MJ, Brunner M, Feng FY, Zwart W, Knudsen KE. Shafi AA, et al. Among authors: schiewer mj. Nat Commun. 2021 Jan 15;12(1):401. doi: 10.1038/s41467-020-20513-5. Nat Commun. 2021. PMID: 33452241 Free PMC article.
DNA Damage Response in Prostate Cancer.
Schiewer MJ, Knudsen KE. Schiewer MJ, et al. Cold Spring Harb Perspect Med. 2019 Jan 2;9(1):a030486. doi: 10.1101/cshperspect.a030486. Cold Spring Harb Perspect Med. 2019. PMID: 29530944 Free PMC article. Review.
PARP Inhibitors in Prostate Cancer.
Ramakrishnan Geethakumari P, Schiewer MJ, Knudsen KE, Kelly WK. Ramakrishnan Geethakumari P, et al. Among authors: schiewer mj. Curr Treat Options Oncol. 2017 Jun;18(6):37. doi: 10.1007/s11864-017-0480-2. Curr Treat Options Oncol. 2017. PMID: 28540598 Review.
Transcriptional roles of PARP1 in cancer.
Schiewer MJ, Knudsen KE. Schiewer MJ, et al. Mol Cancer Res. 2014 Aug;12(8):1069-80. doi: 10.1158/1541-7786.MCR-13-0672. Epub 2014 Jun 10. Mol Cancer Res. 2014. PMID: 24916104 Free PMC article. Review.
Linking DNA Damage and Hormone Signaling Pathways in Cancer.
Schiewer MJ, Knudsen KE. Schiewer MJ, et al. Trends Endocrinol Metab. 2016 Apr;27(4):216-225. doi: 10.1016/j.tem.2016.02.004. Epub 2016 Mar 1. Trends Endocrinol Metab. 2016. PMID: 26944914 Free PMC article. Review.
PARP-1 regulates DNA repair factor availability.
Schiewer MJ, Mandigo AC, Gordon N, Huang F, Gaur S, de Leeuw R, Zhao SG, Evans J, Han S, Parsons T, Birbe R, McCue P, McNair C, Chand SN, Cendon-Florez Y, Gallagher P, McCann JJ, Poudel Neupane N, Shafi AA, Dylgjeri E, Brand LJ, Visakorpi T, Raj GV, Lallas CD, Trabulsi EJ, Gomella LG, Dicker AP, Kelly WK, Leiby BE, Knudsen B, Feng FY, Knudsen KE. Schiewer MJ, et al. EMBO Mol Med. 2018 Dec;10(12):e8816. doi: 10.15252/emmm.201708816. EMBO Mol Med. 2018. PMID: 30467127 Free PMC article.
Mutant p53 elicits context-dependent pro-tumorigenic phenotypes.
McCann JJ, Vasilevskaya IA, McNair C, Gallagher P, Neupane NP, de Leeuw R, Shafi AA, Dylgjeri E, Mandigo AC, Schiewer MJ, Knudsen KE. McCann JJ, et al. Among authors: schiewer mj. Oncogene. 2022 Jan;41(3):444-458. doi: 10.1038/s41388-021-01903-5. Epub 2021 Nov 12. Oncogene. 2022. PMID: 34773073
The AR dependent cell cycle: mechanisms and cancer relevance.
Schiewer MJ, Augello MA, Knudsen KE. Schiewer MJ, et al. Mol Cell Endocrinol. 2012 Apr 16;352(1-2):34-45. doi: 10.1016/j.mce.2011.06.033. Epub 2011 Jul 12. Mol Cell Endocrinol. 2012. PMID: 21782001 Free PMC article. Review.
38 results